GlassScriptPhysician profile
Kyle Lr Sperling
NPI 1710071295
$2,006.00
in general payments reported to CMS, 2019-2025
25 companies · $814 in 2025
The $814 reported for 2025 was more than what 76% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $175 · 2022: $436 · 2023: $306 · 2024: $276 · 2025: $814.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,395.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,395.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vanda Pharmaceuticals INC. | $276.88 | 2022-2025 | Fanapt |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $267.92 | 2022-2025 | Caplyta |
| Viiv Healthcare Company | $250.73 | 2022-2025 | Apretude, Rukobia, Dovato |
| Novo Nordisk INC | $154.26 | 2022-2025 | Ozempic, Rybelsus |
| Lilly USA, LLC | $153.38 | 2023-2025 | Zepbound, Mounjaro, Emgality |
| Axsome Therapeutics, INC. | $138.71 | 2025 | Auvelity |
| Otsuka America Pharmaceutical, INC. | $117.31 | 2022-2025 | Rexulti, Abilify Asimtufii, Nuedexta |
| Abbvie INC. | $114.57 | 2022-2025 | |
| Janssen Biotech, INC. | $77.42 | 2022-2023 | Symtuza |
| Bayer Healthcare Pharmaceuticals INC. | $60.72 | 2022 | |
| Pfizer INC. | $57.52 | 2023-2025 | |
| Gilead Sciences, INC. | $40.66 | 2023-2025 | Descovy |
| Medtronic, INC. | $34.97 | 2021 | |
| Travere Therapeutics, INC. | $34.35 | 2021 | |
| Glaxosmithkline, LLC. | $31.98 | 2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $30.35 | 2021 | |
| Sk Life Science, INC. | $27.60 | 2022 | |
| Myovant Sciences INC. | $22.53 | 2021 | |
| Janssen Scientific Affairs, LLC | $21.19 | 2021 | |
| Exact Sciences Corporation | $17.21 | 2023 | Cologuard Collection Kit |
| Phathom Pharmaceuticals, INC. | $16.59 | 2025 | Voquezna |
| Blue Earth Diagnostics | $15.67 | 2021 | |
| Urovant Sciences INC | $15.49 | 2021 | |
| Shield Therapeutics INC | $14.42 | 2024 | |
| Teva Pharmaceuticals USA, INC. | $13.57 | 2023 | Austedo Xr |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Sperling listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.